ABIONYX Pharma S.A.

ABNX.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-€4-€4-€4-€6
Dep. & Amort.€0€0€0€0
Deferred Tax€0€0€0-€1
Stock-Based Comp.€0€0€1€1
Change in WC-€0€1€0-€2
Other Non-Cash€1-€1€0€1
Operating Cash Flow-€4-€4-€3-€7
Investing Activities
PP&E Inv.-€0-€0-€0-€0
Net Acquisitions€0€0€0€2
Inv. Purchases€0€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.-€0-€0€0€0
Investing Cash Flow-€0-€0-€0€1
Financing Activities
Debt Repay.-€0-€0-€0-€0
Stock Issued€3€4€0€4
Stock Repurch.-€0€0€0-€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€0€0€0€0
Financing Cash Flow€3€4-€0€4
Forex Effect-€0€0€0€0
Net Chg. in Cash-€1€0-€4-€1
Supplemental Information
Beg. Cash€4€4€8€9
End Cash€3€4€4€8
Free Cash Flow-€4-€4-€4-€7